FACOの膵がん研究 ESMO GI 2025でポスター発表

 FACO’s pancreatic cancer study: Poster presentation at ESMO GI 2025

2025年7月2日～5日にスペイン・バルセロナで開催されたESMO GI （The ESMO Gastrointestinal Cancers Congress 2025）でFACOで実施の膵がん研究PC-CURE-1のサブ解析の一つ「Prognostic significance of CA19-9 before conversion surgery for patients with initially unresectable pancreatic cancer」がポスターで発表されました。

発表者は神奈川県立がんセンター 小林智先生です。

At the ESMO Gastrointestinal Cancers Congress 2025 (ESMO GI), held in Barcelona, Spain from 2 to 5 July 2025 one of the subgroup analyses from the FACO pancreatic cancer study PC-CURE-1 was presented as a poster.

The presentation, titled “Prognostic significance of CA19-9 before conversion surgery for patients with initially unresectable pancreatic cancer”, was delivered by Dr. Satoshi Kobayashi from Kanagawa Cancer Center.